KRYSTA CLARK: Open Payments
NPI 1366094914 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 40 payments from 11 companies in 2025. Trend: 2023 $124 · 2024 $631 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $275 |
| Novo Nordisk Inc | 7 | $155 |
| Lilly USA, LLC | 5 | $109 |
| ABBVIE INC. | 4 | $82 |
| Exact Sciences Corporation | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| PFIZER INC. | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: FARXIGA, MOUNJARO, AIRSUPRA, VRAYLAR, Cologuard Collection Kit, JARDIANCE, Ozempic, Rybelsus.
Industry payments across FL — which companies pay providers there.
